Human Rabies Vaccine: Market Outlook
Rabies remains a public health challenge in many regions, with thousands of fatalities annually. The Human Rabies Vaccine Market is witnessing significant demand, driven by rising awareness, preventive vaccination programs, and growing pet ownership.
Advancements in vaccine formulations, such as purified Vero cell-based vaccines, have improved safety and efficacy. Governments and NGOs are investing in mass vaccination campaigns, particularly in Asia and Africa where rabies prevalence is highest. The market is expected to expand with better cold-chain logistics, enhanced coverage in rural areas, and integration of novel immunization technologies.
11 Views